
A company insider recently bought 7,800 shares of Immunome Inc [IMNM]. Should You Buy?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $60684.0 on Mar 25 ’25.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $60684.0 on Mar 25
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Immunome Inc
Immunome Inc’s filing revealed that its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $1.16 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Immunome Inc’s filing revealed that its President and CEO SIEGALL CLAY B acquired Company’s shares for reported $1.16 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.